The primary risk factors for stroke in PV patients are age, JAK2 exon V617F mutation (JAK2/V617F), as well as previous history of thrombosis, and early diagnosis can improve the management and clinical outcomes of patients. The gene discussed is JAK2; the disease is acquired polycythemia vera.